pharmaceuticals

Doctor, Health (pulse) copy

Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win

Shares of Array BioPharma Inc. (NASDAQ: ARRY) saw a handy gain in Tuesdays session following the announcement of mid-stage results from its cardiomyopathy trial. These trial results were presented at ...
Read Full Story »
clinical trials

Why Rigel Pharma Is Making a Run

Shares of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) skyrocketed early on Tuesday after the company reported incredibly positive results from its late-stage blood platelet clinical trial. The company announced that fostamatinib, ...
Read Full Story »
white pills

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

In recent weeks, major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco. But now a key research firm is seeing one of these companies ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
road fork sign

Concerns Persist on Mylan EpiPen Price Gouging — or Do They?

Mylan N.V. (NASDAQ: MYL) has been controversial for some time now. As a top player in the world of generics and having brand drugs, it should be in a great place. ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
Female patient on gurney

Thursday’s Top Health Care Stocks Punishing Investors

On Thursday, a few companies in the biotech and pharmaceutical industries made substantial runs. In this case it was all downward, due to the results of U.S. Food and Drug ...
Read Full Story »
choose happiness

Why Valeant Got Its First Big Analyst Upgrade of 2016

Valeant Pharmaceuticals International Inc. (NYSE: VRX) has been on the rise in the past month on increasingly positive news surrounding the company’s position. It seems like Joe Papa’s involvement as ...
Read Full Story »
Medicine pills

Tuesday’s Top Health Care Movers

On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of U.S. Food and Drug Administration (FDA) approvals, failed or passed trials and ...
Read Full Story »
thumbs up

Why Every Analyst in the World Loves Patheon Even After a Strong IPO

Patheon N.V. (NYSE: PTHN) saw its quiet period come to an end on Monday, and the analyst floodgates opened wide. Many calls were made on Monday, but Tuesday brought follow-on ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
Female patient on gurney

Why Aurinia Pharma Is Getting Slaughtered

Shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) were halved early in Monday’s session following a mid-stage trial hiccup. The company announced that it reached its primary endpoint in its Phase 2b Aura-LV ...
Read Full Story »
Test tubes

Top Biotechs Are Among Jefferies Growth Stock Favorites

One thing that has stretched multiples in the S&P 500 this year to a pricey 17 times earnings is that many people have chased a few stocks in the index ...
Read Full Story »
marijuana

Marijuana News Roundup: Cities and States Gearing Up

The biggest bit of marijuana industry news in the week ending August 12 was that the Drug Enforcement Agency (DEA) rejected a call to loosen federal restrictions on marijuana. In ...
Read Full Story »
white pills

Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas

We have written at length on the beating the biotechs have endured. Another sub-sector that has been right alongside for the trip to the Wall Street woodshed has been specialty ...
Read Full Story »